Pharmacokinetic analysis of the uptake of liposomes by macrophages and foam cells in vitro and their distribution to atherosclerotic lesions in mice

被引:25
作者
Chono, Sumio [1 ]
Tauchi, Yoshihiko [1 ]
Morimoto, Kazuhiro [1 ]
机构
[1] Hokkaido Pharmaceut Univ, Dept Pharmaceut, Otaru, Hokkaido 0470264, Japan
关键词
liposomes; particle size; macrophages and foam cells; atherogenic mice; drug delivery system;
D O I
10.2133/dmpk.21.37
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In order to evaluate the efficacy of liposomes as a drug carrier for atherosclerotic therapy, a pharmacokinetic analysis of the uptake of liposomes by macrophages and foam cells in vitro and their distribution to atherosclerotic lesions in mice was carried out. In brief, liposomes of three particle sizes (500, 200 and 70 nm) were prepared, and the uptake of liposomes by these cells in vitro and the aortic distribution following intravenous administration to atherogenic mice were examined. The internalization rate constant calculated by measuring uptake and binding was size-dependent in both types of cells in vitro. The aortic clearance (CLa) was size-independent in atherogenic mice and the CLa of 200 nm particles was the highest. Surprisingly, the aortic distribution in vivo did not correspond with the internalization to macrophages and foam cells in vitro. These results suggest that there is an optimal size for the distribution of liposomes to atherosclerotic lesions.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 33 条
[21]   USE OF RADIOLABELED HEXADECYL CHOLESTERYL ETHER AS A LIPOSOME MARKER [J].
POOL, GL ;
FRENCH, ME ;
EDWARDS, RA ;
HUANG, L ;
LUMB, RH .
LIPIDS, 1982, 17 (06) :448-452
[22]   Mechanisms of disease - Atherosclerosis - An inflammatory disease [J].
Ross, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) :115-126
[23]   THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S [J].
ROSS, R .
NATURE, 1993, 362 (6423) :801-809
[24]   CHOLESTERYL ESTER ACCUMULATION IN MACROPHAGES TREATED WITH OXIDIZED LOW-DENSITY-LIPOPROTEIN [J].
RYU, BH ;
MAO, FW ;
LOU, PP ;
GUTMAN, RL ;
GREENSPAN, P .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1995, 59 (09) :1619-1622
[25]   Preparation of a complex of dexamethasone palmitate-low density lipoprotein and its effect on foam cell formation of murine peritoneal macrophages [J].
Tauchi, Y ;
Takase, M ;
Zushida, I ;
Chono, S ;
Sato, J ;
Ito, K ;
Morimoto, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (07) :709-714
[26]   Effect of dexamethasone palmitate-low density lipoprotein complex on cholesterol ester accumulation in aorta of atherogenic model mice [J].
Tauchi, Y ;
Zushida, I ;
Chono, S ;
Sato, J ;
Ito, K ;
Morimoto, K .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (08) :925-929
[27]  
Tauchi Y, 2000, BIOL PHARM BULL, V23, P466
[28]  
TEDGUI A, 1994, EUR CYTOKINE NETW, V5, P263
[29]   Dexamethasone influences intimal thickening and vascular reactivity in the rabbit collared carotid artery [J].
VanPut, DJM ;
VanHove, CE ;
DeMeyer, GRY ;
Wuyts, F ;
Herman, AG ;
Bult, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) :753-761
[30]   ROLE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN ATHEROGENESIS [J].
WITZTUM, JL ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1785-1792